Home Carboxes 298681-10-4
298681-10-4,MFCD14635712
Catalog No.:AA00I5G6

298681-10-4 | tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
96%
in stock  
$594.00   $416.00
- +
5g
96%
in stock  
$1,640.00   $1,148.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00I5G6
Chemical Name:
tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate
CAS Number:
298681-10-4
Molecular Formula:
C9H17NO4
Molecular Weight:
203.2356
MDL Number:
MFCD14635712
SMILES:
OC1CN(CC1O)C(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
213  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
2  
XLogP3:
-0.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ACADIAPHARMACEUTICALSINC-WO2005/115361,2005,A2Locationinpatent:Page/Pagecolumn68-69

[1]CurrentPatentAssignee:SANOFI-US6750348,2004,B1Locationinpatent:Pagecolumn118

[1]CurrentPatentAssignee:PERRIGOCOMPANYPUBLICLIMITEDCOMPANY-WO2007/22502,2007,A2Locationinpatent:Page/Pagecolumn86

[2]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[3]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[4]CurrentPatentAssignee:SANOFI-US6750348,2004,B1Locationinpatent:Pagecolumn117-118

[5]CurrentPatentAssignee:ASTRAZENECAPLC-WO2003/82831,2003,A1Locationinpatent:Page/Pagecolumn149

[6]Locationinpatent:schemeortableBowers,Simeon;Probst,GaryD.;Truong,AnhP.;Hom,RoyK.;Konradi,AndreiW.;Sham,HingL.;Garofalo,AlbertW.;Wong,Karina;Goldbach,Erich;Quinn,KevinP.;Sauer,John-Michael;Wallace,William;Nguyen,Lan;Hemphill,SusannaS.;Bova,MichaelP.;Basi,GuriqbalS.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#24,p.6952-6956]

[7]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2021/115065,2021,A1Locationinpatent:Paragraph0681;0714-0715

[1]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[2]CurrentPatentAssignee:ARVINAS-WO2022/47145,2022,A1Locationinpatent:Paragraph00287

[3]Locationinpatent:schemeortableBowers,Simeon;Probst,GaryD.;Truong,AnhP.;Hom,RoyK.;Konradi,AndreiW.;Sham,HingL.;Garofalo,AlbertW.;Wong,Karina;Goldbach,Erich;Quinn,KevinP.;Sauer,John-Michael;Wallace,William;Nguyen,Lan;Hemphill,SusannaS.;Bova,MichaelP.;Basi,GuriqbalS.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#24,p.6952-6956]

[4]CurrentPatentAssignee:PERRIGOCOMPANYPUBLICLIMITEDCOMPANY-WO2007/22502,2007,A2Locationinpatent:Page/Pagecolumn86

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US2021/115065,2021,A1Locationinpatent:Paragraph0681;0716

[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2003/82831,2003,A1Locationinpatent:Page/Pagecolumn149

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:298681-10-4 Molecular Formula|298681-10-4 MDL|298681-10-4 SMILES|298681-10-4 tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate